about us | our approach | our expertise | solutions | case studies | clients | news & events | contact
 
 
 


   
 
News & events
College Hill
August 2008

College Hill Appointed by ValiRx and NextGen Sciences for Integrated Financial Communications Programmes

London, August 2008   College Hill’s Life Sciences team has been appointed by ValiRx (AIM: VAL), London, UK, to develop and implement an integrated financial and corporate communications programme to raise its profile as a leader in the field of cancer therapeutics and diagnostics.

Sue Charles, Managing Partner, Life Sciences and Adrian Duffield, Partner, TMT and Life Sciences will lead the account for ValiRx, supported by Justine Lamond, Account Manager, and Dr John McIntyre.

ValiRx is a biopharmaceutical company that delivers novel technologies and products in oncology therapeutics and diagnostics. Although primarily focused on epigenomic analysis and the treatment of cancer, its technologies can also be applied across fields such as neurology and inflammatory diseases. ValiRx is headquartered in London, UK, and operates through two divisions: ValiPharma, focused on cancer therapeutics; and ValiBio, focused on cancer diagnostics. www.valirx.com

Commenting on the wins, Sue Charles, Managing Partner Life Sciences said: "We are extremely pleased to have been chosen to support ValiRx with its financial communications programme. The win further extends our portfolio of listed clients in the life science field".

For further information:
Sue Charles, Managing Partner – Life Sciences, College Hill
+44 (0)20 7457 2020
sue.charles[at]collegehill.com

© 2008 College Hill – Life Sciences

News
Events
In the News
Newsletters